Published in BMC Genomics on October 27, 2014
An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets. BMC Genomics (2015) 0.85
Encyclopedia of bacterial gene circuits whose presence or absence correlate with pathogenicity--a large-scale system analysis of decoded bacterial genomes. BMC Genomics (2015) 0.75
An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach. Int J Mol Sci (2017) 0.75
Novel Drug Targets for Food-Borne Pathogen Campylobacter jejuni: An Integrated Subtractive Genomics and Comparative Metabolic Pathway Study. OMICS (2015) 0.75
Essential genome of Campylobacter jejuni. BMC Genomics (2017) 0.75
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov (2004) 15.57
The druggable genome. Nat Rev Drug Discov (2002) 13.61
The HMMTOP transmembrane topology prediction server. Bioinformatics (2001) 12.57
Protein structure prediction and structural genomics. Science (2001) 11.76
UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford) (2011) 11.43
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res (2006) 9.19
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res (2009) 7.33
The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res (2004) 7.21
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics (2005) 6.82
Ribonucleotide reductases. Annu Rev Biochem (2006) 6.35
Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci (2007) 5.81
Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) (2006) 4.84
MolDock: a new technique for high-accuracy molecular docking. J Med Chem (2006) 4.33
Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res (2006) 3.47
PDBe: Protein Data Bank in Europe. Nucleic Acids Res (2011) 3.03
Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci (2004) 3.02
Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov (2008) 2.58
DEG: a database of essential genes. Nucleic Acids Res (2004) 2.42
Vesicular glycolysis provides on-board energy for fast axonal transport. Cell (2013) 2.33
Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett (2003) 2.30
An essential two-component signal transduction system in Mycobacterium tuberculosis. J Bacteriol (2000) 2.16
Ribonucleotide reductase: regulation, regulation, regulation. Trends Biochem Sci (1992) 2.07
Structural basis for activation of class Ib ribonucleotide reductase. Science (2010) 2.07
Comparison of the NCI open database with seven large chemical structural databases. J Chem Inf Comput Sci (2001) 2.03
Using the Basic Local Alignment Search Tool (BLAST). CSH Protoc (2007) 2.03
Comparison between rpoB and 16S rRNA gene sequencing for molecular identification of 168 clinical isolates of Corynebacterium. J Clin Microbiol (2005) 1.94
GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene (2006) 1.65
A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol (2004) 1.62
Caseous lymphadenitis in small ruminants. Vet Clin North Am Food Anim Pract (2001) 1.61
Structural biology and drug discovery. Drug Discov Today (2005) 1.59
Human lymphadenitis due to Corynebacterium pseudotuberculosis: report of ten cases from Australia and review. Clin Infect Dis (1997) 1.51
Two biochemically distinct classes of fumarase in Escherichia coli. Biochim Biophys Acta (1988) 1.50
Expression analysis of the nrdHIEF operon from Escherichia coli. Conditions that trigger the transcript level in vivo. J Biol Chem (2001) 1.49
Homology modeling in drug discovery: current trends and applications. Drug Discov Today (2009) 1.47
The multisubunit active site of fumarase C from Escherichia coli. Nat Struct Biol (1995) 1.40
Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis (2010) 1.39
An active dimanganese(III)-tyrosyl radical cofactor in Escherichia coli class Ib ribonucleotide reductase. Biochemistry (2010) 1.31
Domain orientation in the inactive response regulator Mycobacterium tuberculosis MtrA provides a barrier to activation. Biochemistry (2007) 1.27
Towards pathogenomics: a web-based resource for pathogenicity islands. Nucleic Acids Res (2006) 1.24
NrdI, a flavodoxin involved in maintenance of the diferric-tyrosyl radical cofactor in Escherichia coli class Ib ribonucleotide reductase. Proc Natl Acad Sci U S A (2008) 1.23
The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium. Antimicrob Agents Chemother (2006) 1.21
In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol (2009) 1.17
In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol (2006) 1.17
A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One (2009) 1.17
The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. Structure (2000) 1.15
Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production. J Biotechnol (2012) 1.12
In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets. In Silico Biol (2006) 1.11
Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification. In Silico Biol (2007) 1.09
The lytB gene of Escherichia coli is essential and specifies a product needed for isoprenoid biosynthesis. J Bacteriol (2001) 1.08
DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics (2012) 1.06
Identifying essential genes in bacterial metabolic networks with machine learning methods. BMC Syst Biol (2010) 1.01
Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem (2001) 1.00
Discovery of acetylene hydratase activity of the iron-sulphur protein IspH. Nat Commun (2012) 0.99
Corynebacterium pseudotuberculosis is a cause of human necrotising granulomatous lymphadenitis. Pathology (1997) 0.99
Structural studies of duck delta 1 and delta 2 crystallin suggest conformational changes occur during catalysis. Biochemistry (2001) 0.98
Substrate and product complexes of Escherichia coli adenylosuccinate lyase provide new insights into the enzymatic mechanism. J Mol Biol (2007) 0.98
Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates. PLoS One (2012) 0.95
Structure-function relationship in serine hydroxymethyltransferase. Biochim Biophys Acta (2003) 0.94
Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics (2011) 0.93
Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors. J Mol Biol (2001) 0.93
Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design. J Med Chem (1998) 0.92
Genome subtraction for novel target definition in Salmonella typhi. Bioinformation (2009) 0.91
Survival of Corynebacterium pseudotuberculosis in axenic purulent exudate on common barnyard fomites. Am J Vet Res (1986) 0.89
Dataset of potential targets for Mycobacterium tuberculosis H37Rv through comparative genome analysis. Bioinformation (2009) 0.89
The structure of L-aspartate ammonia-lyase from Escherichia coli. Biochemistry (1997) 0.89
A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens. Chem Biol Drug Des (2011) 0.88
ARTEMIS: a tool for displaying and annotating DNA sequence. Brief Bioinform (2000) 0.86
Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment. BMC Genomics (2010) 0.85
The crystal structure of Mycobacterium tuberculosis adenylate kinase in complex with two molecules of ADP and Mg2+ supports an associative mechanism for phosphoryl transfer. Protein Sci (2006) 0.84
Crystal structure of 3-carboxy-cis,cis-muconate lactonizing enzyme from Pseudomonas putida, a fumarase class II type cycloisomerase: enzyme evolution in parallel pathways. Biochemistry (2004) 0.84
Plasmodium serine hydroxymethyltransferase as a potential anti-malarial target: inhibition studies using improved methods for enzyme production and assay. Malar J (2012) 0.84
Whole-genome sequence of Corynebacterium pseudotuberculosis strain Cp162, isolated from camel. J Bacteriol (2012) 0.84
Inhibition of Plasmodium falciparum ispH (lytB) gene expression by hammerhead ribozyme. Oligonucleotides (2007) 0.82
Conserved host-pathogen PPIs. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds. Integr Biol (Camb) (2013) 0.82
A herd level analysis of a Corynebacterium pseudotuberculosis outbreak in a dairy cattle herd. Vet Dermatol (2004) 0.81
Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase. Bioorg Med Chem (2010) 0.81
Catalytic mechanisms and biocatalytic applications of aspartate and methylaspartate ammonia lyases. ACS Chem Biol (2012) 0.81
Conformational changes upon ligand binding in the essential class II fumarase Rv1098c from Mycobacterium tuberculosis. FEBS Lett (2012) 0.80
Molecular modeling and docking analysis of Entamoeba histolytica glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development. Chem Biol Drug Des (2008) 0.79
In silico biology of H1N1: molecular modelling of novel receptors and docking studies of inhibitors to reveal new insight in flu treatment. J Biomed Biotechnol (2012) 0.79
Target genes, consensus binding site, and role of phosphorylation for the response regulator MtrA of Corynebacterium glutamicum. J Bacteriol (2010) 0.79
[Alcohol and drugs: preliminary survey of Brazilian nursing research]. Rev Lat Am Enfermagem (2006) 0.78
Characterization of a functional C-terminus of the Mycobacterium tuberculosis MtrA responsible for both DNA binding and interaction with its two-component partner protein, MtrB. J Biochem (2010) 0.77
Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori. Biometals (2011) 0.76
A molecular phylogeny of living primates. PLoS Genet (2011) 5.61
Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res (2006) 3.47
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. Lancet Oncol (2010) 2.74
Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med (2004) 2.35
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00
Rapid hybrid de novo assembly of a microbial genome using only short reads: Corynebacterium pseudotuberculosis I19 as a case study. J Microbiol Methods (2011) 1.76
Comparative analysis of two complete Corynebacterium ulcerans genomes and detection of candidate virulence factors. BMC Genomics (2011) 1.75
Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. PLoS One (2011) 1.53
Enantioselective total syntheses of manzamine a and related alkaloids. J Am Chem Soc (2002) 1.52
Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res (2003) 1.48
Multiplex PCR assay for identification of Corynebacterium pseudotuberculosis from pure cultures and for rapid detection of this pathogen in clinical samples. J Med Microbiol (2007) 1.45
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact (2005) 1.45
Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts. PLoS One (2009) 1.44
The pan-genome of the animal pathogen Corynebacterium pseudotuberculosis reveals differences in genome plasticity between the biovar ovis and equi strains. PLoS One (2013) 1.42
Structure based sequence analysis & epitope prediction of gp41 HIV1 envelope glycoprotein isolated in Pakistan. Genet Vaccines Ther (2012) 1.41
Analysis of quality raw data of second generation sequencers with Quality Assessment Software. BMC Res Notes (2011) 1.40
Complete genome sequence of Corynebacterium pseudotuberculosis I19, a strain isolated from a cow in Israel with bovine mastitis. J Bacteriol (2010) 1.35
Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol (2002) 1.33
Physicochemical characteristics of various milk samples available in Pakistan. J Zhejiang Univ Sci B (2008) 1.31
Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif (2011) 1.26
Tips and tricks for the assembly of a Corynebacterium pseudotuberculosis genome using a semiconductor sequencer. Microb Biotechnol (2012) 1.26
The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence. BMC Genomics (2010) 1.24
Genome sequence of Exiguobacterium antarcticum B7, isolated from a biofilm in Ginger Lake, King George Island, Antarctica. J Bacteriol (2012) 1.24
PIPS: pathogenicity island prediction software. PLoS One (2012) 1.23
Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb Cell Fact (2006) 1.22
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther (2012) 1.19
Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol (2009) 1.19
Pangenomic study of Corynebacterium diphtheriae that provides insights into the genomic diversity of pathogenic isolates from cases of classical diphtheria, endocarditis, and pneumonia. J Bacteriol (2012) 1.19
Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS One (2010) 1.19
The use of brain positron emission tomography to identify sites of postoperative pain processing with and without epidural analgesia. Anesth Analg (2007) 1.18
The addictive brain: all roads lead to dopamine. J Psychoactive Drugs (2012) 1.16
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 May 2009-31 July 2009. Mol Ecol Resour (2009) 1.15
Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect (2005) 1.13
Simplifier: a web tool to eliminate redundant NGS contigs. Bioinformation (2012) 1.13
Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production. J Biotechnol (2012) 1.12
The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun (2010) 1.08
Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J Med Microbiol (2002) 1.07
Differential transcriptional profile of Corynebacterium pseudotuberculosis in response to abiotic stresses. BMC Genomics (2014) 1.07
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care (2008) 1.07
Genome-wide transcriptomic analysis of cotton under drought stress reveal significant down-regulation of genes and pathways involved in fibre elongation and up-regulation of defense responsive genes. Plant Mol Biol (2011) 1.06
Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microbiol (2006) 1.05
Diversity of lactic acid bacteria of the bioethanol process. BMC Microbiol (2010) 1.03
Preaxial polydactyly/triphalangeal thumb is associated with changed transcription factor-binding affinity in a family with a novel point mutation in the long-range cis-regulatory element ZRS. Eur J Hum Genet (2010) 1.03
Oxidative stress in Lactococcus lactis. Genet Mol Res (2003) 1.03
CHIP chaperones wild type p53 tumor suppressor protein. J Biol Chem (2007) 1.03
Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol (2014) 1.03
Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice. Infect Immun (2002) 1.01
Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors. Int J Environ Res Public Health (2011) 1.01
Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis (2011) 1.00
CoryneRegNet 6.0--Updated database content, new analysis methods and novel features focusing on community demands. Nucleic Acids Res (2011) 0.99
Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice. Clin Dev Immunol (2011) 0.99
A new plasmid vector for DNA delivery using lactococci. Genet Vaccines Ther (2009) 0.99
Corynebacterium pseudotuberculosis secreted antigen-induced specific gamma-interferon production by peripheral blood leukocytes: potential diagnostic marker for caseous lymphadenitis in sheep and goats. J Vet Diagn Invest (2011) 0.99
Complete genome sequence of Corynebacterium pseudotuberculosis strain Cp267, isolated from a llama. J Bacteriol (2012) 0.97